Hancock Whitney’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $831K | Sell |
38,285
-562
| -1% | -$12.2K | 0.02% | 459 |
|
|
2025
Q1 | $942K | Buy |
38,847
+525
| +1% | +$12.7K | 0.03% | 324 |
|
|
2024
Q4 | $800K | Sell |
38,322
-606
| -2% | -$12.6K | 0.03% | 344 |
|
|
2024
Q3 | $774K | Sell |
38,928
-1,928
| -5% | -$38.3K | 0.02% | 362 |
|
|
2024
Q2 | $633K | Buy |
40,856
+88
| +0.2% | +$1.36K | 0.02% | 373 |
|
|
2024
Q1 | $650K | Buy |
40,768
+12,361
| +44% | +$197K | 0.02% | 376 |
|
|
2023
Q4 | $478K | Sell |
28,407
-470
| -2% | -$7.9K | 0.02% | 450 |
|
|
2023
Q3 | $338K | Sell |
28,877
-65
| -0.2% | -$760 | 0.01% | 501 |
|
|
2023
Q2 | $388K | Buy |
28,942
+14,227
| +97% | +$191K | 0.02% | 478 |
|
|
2023
Q1 | $244K | Sell |
14,715
-103
| -0.7% | -$1.71K | 0.01% | 578 |
|
|
2022
Q4 | $275K | Buy |
+14,818
| New | +$275K | 0.01% | 550 |
|
|
2021
Q3 | – | Sell |
-238,281
| Closed | -$1.37M | – | 696 |
|
|
2021
Q2 | $1.37M | Sell |
238,281
-208
| -0.1% | -$1.2K | 0.04% | 353 |
|
|
2021
Q1 | $1.1M | Sell |
238,489
-803
| -0.3% | -$3.7K | 0.04% | 390 |
|
|
2020
Q4 | $799K | Sell |
239,292
-53,928
| -18% | -$180K | 0.03% | 426 |
|
|
2020
Q3 | $871K | Sell |
293,220
-24,690
| -8% | -$73.3K | 0.03% | 396 |
|
|
2020
Q2 | $1.47M | Buy |
+317,910
| New | +$1.47M | 0.06% | 295 |
|